project id: TCGA-LUAD; case submitter id: TCGA-64-1681; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; a260 a280 ratio: 2.0; normal tumor genotype snp match: Yes; age at index: 61; days to birth: -22525; days to death: 1167; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1947; year of death: 2011; age at diagnosis: 22525; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lung, NOS; synchronous malignancy: No; tissue or organ of origin: Lung, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; years smoked: 20.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.4; longest dimension: 0.8; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-64-1681-01A-11; percent neutrophil infiltration: 5.0; percent normal cells: 0.0;